Catalyst Wire Dossier Catalyst Wire Dossier

Concerta (OROS-Methylphenidate)

methylphenidate hydrochloride (OROS formulation)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Concerta (OROS-Methylphenidate), covering 2009-02-12 to 2009-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD) [Phase 4]

See pricing